| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e62898e7789eacc784f239af0e1ccea |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2013-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bad0108dd6c63369520b374412da6ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c748b57dbd76c74a1e8f850fe9601e |
| publicationDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013186398-A1 |
| titleOfInvention |
Tfeb for use in treating obesity or metabolic syndrome |
| abstract |
The present invention refers to a vector for gene therapy comprising a TFEB coding sequence under the control of a promoter able to efficiently express said TFEB coding sequence, to host cell comprising said vector and to their use in the treatment of obesity and/or metabolic syndrome. The present invention also refers to a pharmaceutical composition comprising the vector or the host cell of the invention for therapy and to a method of treatment of obesity and/or metabolic syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11567064-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112912112-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114630898-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020084162-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018060697-A1 |
| priorityDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |